CORC  > 高能物理研究所
Precision combination therapy for triple negative breast cancer via biomimetic polydopamine polymer core-shell nanostructures
Ding, Yanping1,2; Su, Shishuai1,2; Zhang, Ruirui1; Shao, Leihou1,2; Zhang, Yinlong1,3; Wang, Bin1,2; Li, Yiye1,2; Chen, Long1,2; Yu, Qun4; Wu, Yan1
刊名Biomaterials
2017
卷号113页码:243-252
关键词Spatiotemporal-controlled drug release Thermo-responsive Photothermal therapy Chemotherapy Small interfering rna
ISSN号0142-9612
DOI10.1016/j.biomaterials.2016.10.053
通讯作者Wu, yan(wuy@nanoctr.cn) ; Nie, guangjun(niegj@nanoctr.cn)
英文摘要Photothermal-based combination therapy using functional nanomaterials shows great promise in eradication of aggressive tumors and improvement of drug sensitivity. the therapeutic efficacy and adverse effects of drug combinations depend on the precise control of timely tumor-localized drug release. here a polymer-dopamine nanocomposite is designed for combination therapy, thermo-responsive drug release and prevention of uncontrolled drug leakage. the thermo-sensitive co-polymer poly (2-(2-methoxyethoxy) ethyl methacrylate-co-oligo (ethylene glycol) methacrylate)-co-2-(dimethylamino) ethyl methacrylate-b-poly (d, l-lactide-co-glycolide) is constructed into core-shell structured nanoparticles for co-encapsulation of two cytotoxic drugs and absorption of small interfering rnas against survivin. the drug-loaded nanoparticles are surface-coated with polydopamine which confers the nanoformulation with photothermal activity and protects drugs from burst release. under tumor-localized laser irradiation, polydopamine generates sufficient heat, resulting in nano particle collapse and instant drug release within the tumor. the combination strategy of photothermal, chemo-, and gene therapy leads to triple-negative breast cancer regression, with a decrease in the. chemotherapeutic drug dosage to about 1/20 of conventional dose. this study establishes a powerful nanoplatform for precisely controlled combination therapy, with dramatic improvement of therapeutic efficacy and negligible side effects. (c) 2016 elsevier ltd. all rights reserved.
WOS关键词ENHANCED ANTITUMOR EFFICACY ; PHOTOTHERMAL THERAPY ; IN-VITRO ; SURFACE MODIFICATION ; NANOPARTICLES ; DELIVERY ; CHEMOTHERAPY ; DOXORUBICIN ; ENCAPSULATION ; NANOCARRIERS
WOS研究方向Engineering ; Materials Science
WOS类目Engineering, Biomedical ; Materials Science, Biomaterials
语种英语
出版者ELSEVIER SCI LTD
WOS记录号WOS:000389396300020
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/2176619
专题高能物理研究所
通讯作者Wu, Yan; Nie, Guangjun
作者单位1.Natl Ctr Nanosci & Technol NCNST, CAS Ctr Excellence Nanosci, CAS Key Lab Biomed Effects Nanomat & Nanosafety, 11 Beiyitiao, Beijing 100190, Peoples R China
2.Univ Chinese Acad Sci, Beijing 100049, Peoples R China
3.Jilin Univ, Coll Pharmaceut Sci, Changchun 130021, Peoples R China
4.Beijing Inst Transfus Med, Dept Immunohematol, 27 Taiping Rd, Beijing 100850, Peoples R China
推荐引用方式
GB/T 7714
Ding, Yanping,Su, Shishuai,Zhang, Ruirui,et al. Precision combination therapy for triple negative breast cancer via biomimetic polydopamine polymer core-shell nanostructures[J]. Biomaterials,2017,113:243-252.
APA Ding, Yanping.,Su, Shishuai.,Zhang, Ruirui.,Shao, Leihou.,Zhang, Yinlong.,...&Nie, Guangjun.(2017).Precision combination therapy for triple negative breast cancer via biomimetic polydopamine polymer core-shell nanostructures.Biomaterials,113,243-252.
MLA Ding, Yanping,et al."Precision combination therapy for triple negative breast cancer via biomimetic polydopamine polymer core-shell nanostructures".Biomaterials 113(2017):243-252.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace